Projection of Costs of Polio Eradication Compared to Permanent Control
Author(s) -
Marita Zimmermann,
Brittany Hagedorn,
Hil Lyons
Publication year - 2019
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiz488
Subject(s) - poliomyelitis eradication , poliomyelitis , polio vaccination , control (management) , population , vaccination , business , medicine , environmental health , economic growth , immunization , economics , pediatrics , virology , poliovirus , immunology , virus , antigen , management
Despite increased efforts and spending toward polio eradication, it has yet to be eliminated worldwide. We aimed to project economic costs of polio eradication compared to permanent control. We used historical Financial Resource Requirements from the Global Polio Eradication Initiative, as well as vaccination and population data from publicly available sources, to project costs for routine immunization, immunization campaigns, surveillance and laboratory resources, technical assistance, social mobilization, treatment, and overhead. We found that cumulative spending for a control strategy would exceed that for an eradication strategy in 2032 (range, 2027–2051). Eradication of polio would likely be cost-saving compared to permanent control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom